What are the details of the new contracts secured by Pro Medicus (ASX:PME)?

Pro Medicus announced two major deals in the United States totalling A$44 million through its US subsidiary, Visage Imaging. The first is a new seven-year, A$16 million contract with TidalHealth, and the second is a five-year, A$28 million contract renewal with Allegheny Health Network.

Why is the Allegheny Health Network (AHN) renewal significant for Pro Medicus (ASX:PME)?

The A$28 million deal marks AHN's third contract term with Pro Medicus, expanding their partnership to include the Visage 7 Workflow across 14 hospitals and 300 clinical locations. Crucially, the extension was negotiated with higher minimum transaction volumes and increased fees per transaction. This pushes Pro Medicus's total renewals for the current financial year to a massive A$125 million.

What technology is TidalHealth implementing from Pro Medicus (ASX:PME)?

TidalHealth is adopting the full cloud-based Visage 7 platform, which includes the Visage 7 Viewer, Visage 7 Workflow, and Visage 7 Open Archive. Additionally, they have opted for the specialised Visage 7 Cardiology Imaging system.

How do these contract wins impact the medium-term investment thesis for Pro Medicus (ASX:PME)?

These wins strengthen the medium-term thesis by proving Pro Medicus's ability to maintain high client retention while successfully cross-selling new modules like cardiology. The transition of hospital networks to fully cloud-based systems solidifies the company's recurring, transaction-based revenue model.

What are the main bull and bear points for Pro Medicus (ASX:PME) after this news?

The main bull point is the operating leverage gained from higher transaction fees and increased minimum volumes with existing clients like AHN. The primary bear point is that revenue realization is tied to transaction volumes, meaning any macro medical sector slowdown could limit the anticipated financial upside.

What broader industry trend do these Pro Medicus (ASX:PME) deals highlight?

According to Pro Medicus CEO Dr Sam Hupert, these deals reflect a growing trend where large-scale healthcare enterprises look to consolidate disparate, legacy imaging systems into a single, unified enterprise solution.

Image for illustrative purposes only. Not a real photo.

Pro Medicus secures $44M US healthcare deals

Written by Isaac FrancisPublished May. 31 2026Last Updated May. 31 2026

Pro Medicus (ASX:PME) has secured two major contract wins in the United States, totalling $44 million.

The Melbourne-based company’s wholly owned US subsidiary, Visage Imaging, Inc., has signed a new seven-year, $16 million deal with TidalHealth.

The contract introduces Visage’s full cloud-based suite—including the Visage 7 Viewer, Workflow, and Open Archive—alongside their specialised cardiology imaging system.

TidalHealth operates a regional network across Delaware, Maryland, and Virginia, with a formal system rollout targeted for early 2027.

Pro Medicus has locked in a lucrative five-year, $28 million contract renewal with Pittsburgh-based Allegheny Health Network.

The third-term extension expands AHN’s capabilities by integrating the Visage 7 Workflow across its 14 hospitals and 300 clinical locations.

The renewal was negotiated with higher minimum transaction volumes and increased fees per transaction.

Pro Medicus CEO Dr Sam Hupert noted that the AHN extension pushes the company's total renewals for the current financial year to a massive $125 million.

Dr Hupert highlighted a growing industry trend where large-scale healthcare enterprises look to streamline operations by consolidating disparate imaging networks into unified, cloud-hosted platforms.